BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on cyproterone acetate 2 mg/ethinylestradiol 35 µg

Active substance: cyproterone acetate

Strengthening of warnings, new contraindications and updated indication.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 292KB, File is accessible